Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Diagnosis and current management of retinoblastoma

Abstract

Retinoblastoma represents the prototypic model for inherited cancers. The RB1 gene was the first tumor suppressor gene to be identified. It represents the most frequent primary eye cancer in children under 15 years old, habitually occurring in infancy, even in utero, but can be observed in older children or young adults. Many other retinal lesions may also simulate retinoblastoma. The two major presenting signs are leukocoria and strabismus, but other ocular or general signs may be observed. A highly malignant tumor, retinoblastoma can nowadays be cured. The heritable form, however, carries a high risk of second nonocular tumors. Treatment in the early stages of disease holds a good prognosis for survival and salvage of visual function. In very late stages, however, the prognosis for ocular function and even survival is jeopardized.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

References

  • Abramson DH . (1989). Acta Ophthalmol Suppl 194: 3–63.

  • Abramson DH . (1999). Ophthalmic Genet 20: 193–204.

  • Abramson DH, Frank CM . (1998). Ophthalmology 105: 573–580.

  • Abramson DH, Gombos DS . (1996). Retina 16: 232–239.

  • Abramson DH, Melson MR, Dunkel IJ, Frank CM . (2001). Ophthalmology 108: 1868–1876.

  • Aerts I, Leuraud P, Laville I, Blais J, Maillard P, Desjardins L et al. (2005) In International Retinoblastoma Symposium. International Society of Genetic Eye Disease and International Retinoblastoma Symposium: Whistler, Canada.

    Google Scholar 

  • Balmer A, Gailloud C, Munier F, Uffer S, Guex-Crosier Y . (1993). Ophthalmic Paediatr Genet 14: 33–38.

  • Balmer A, Munier F . (2002a) In: Zografos L (ed). Tumeurs Intraoculaires. Société Française d'Ophtalmologie et Masson: Paris, pp 485–533.

    Google Scholar 

  • Balmer A, Munier F . (2002b) In: Zografos L (ed). Tumeurs Intraoculaires. Société Française d'Ophtalmologie et Masson: Paris, pp 481–485.

    Google Scholar 

  • Balmer A, Munier F . (2002c) In: Zografos L (ed). Tumeurs Intraoculaires. Société Française d'Ophtalmologie et Masson: Paris, pp 587–617.

    Google Scholar 

  • Balmer A, Munier F, Gailloud C . (1991). Ophthalmic Paediatr Genet 12: 131–137.

  • Beaverson K, Abramson DH, Lee TC, Hochberg HM, Kirszrot J, Sangani P et al. (2001) In: Keunen JEE, Imhof SM, de Keizer RJW, Moll AC (eds). Xth International Congress of Ocular Oncology. Amsterdam, Conference Proceedings, published by the eds 202.

    Google Scholar 

  • Binder PS . (1974). Am J Ophthalmol 77: 674–679.

  • Chan HS, Gallie BL, Munier FL, Beck Popovic M . (2005). Ophthalmol Clin North Am 18: 55–63, viii.

  • Chantada GL, de Davila MT, Fandino A, Manzitti J, Raslawski E, Casak S et al. (1999). Ophthalmic Genet 20: 133–140.

  • Chevez-Barrios P, Chintagumpala M, Mieler W, Paysse E, Boniuk M, Kozinetz C et al. (2005). J Clin Oncol 23: 7927–7935.

  • Conway RM, Wheeler SM, Murray TG, Jockovich ME, O'Brien JM . (2005). Ophthalmol Clin North Am 18: 25–39 vii.

  • DerKinderen DJ, Koten JW, Tan KE, Beemer FA, Van Romunde LK, Den Otter W . (1990). Am J Ophthalmol 110: 605–609.

  • Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J . (2004). J Natl Cancer Inst 96: 357–363.

  • Gallie BL, Phillips RA . (1984). Ophthalmology 91: 666–672.

  • Gallie BL, Phillips RA, Ellsworth RM, Abramson DH . (1982). Ophthalmology 89: 1393–1399.

  • Girard B, Le Hoang P, D'Hermies F, Quere MA, Rousselie F . (1989). J Fr Ophtalmol 12: 369–381.

  • Huang HJ, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T et al. (1988). Science 242: 1563–1566.

  • Khelfaoui F, Validire P, Auperin A, Quintana E, Michon J, Pacquement H et al. (1996). Cancer 77: 1206–1213.

  • Kivela T . (1999). J Clin Oncol 17: 1829–1837.

  • Kopelman JE, McLean IW, Rosenberg SH . (1987). Ophthalmology 94: 371–377.

  • Maat-Kievit JA, Oepkes D, Hartwig NG, Vermeij-Keers C, van Kamp IL, van de Kamp JJ . (1993). Prenat Diagn 13: 377–384.

  • Mahoney MC, Burnett WS, Majerovics A, Tanenbaum H . (1990). Ophthalmology 97: 1143–1147.

  • Margo CE, Hidayat A, Kopelman J, Zimmerman LE . (1983). Arch Ophthalmol 101: 1519–1531.

  • Matsunaga E, Minoda K, Sasaki MS . (1990). Hum Genet 84: 155–158.

  • Messmer EP, Heinrich T, Höpping W, de Sutter E, Havers W, Sauerwein W . (1991). Ophthalmology 98: 136–141.

  • Miller RW . (1969). J Pediatr 75: 685–689.

  • Morgan G . (1971). Br J Ophthalmol 55: 600.

  • Munier F, Balmer A . (2002) In: Zografos L (ed). Tumeurs Intraoculaires. Société Française d'Ophtalmologie et Masson: Paris, pp 466–487.

    Google Scholar 

  • Murphree AL . (2005). Ophthalmol Clin North Am 18: 41–53, viii.

  • Murray TG, Cicciarelli N, O'Brien JM, Hernandez E, Mueller RL, Smith BJ et al. (1997). Arch Ophthalmol 115: 1286–1290.

  • Reese AB, Ellsworth R . (1963). Trans Am Acad Ophthalmol Otolaryngol 67: 164–172.

  • Scat Y, Liotet S, Carre F . (1996). J Fr Ophtalmol 19: 83–88.

  • Shields CL, Santos MC, Diniz W, Gunduz K, Mercado G, Cater JR et al. (1999). Arch Ophthalmol 117: 885–893.

  • Shields CL, Shields JA, Baez KA, Cater J, De Potter PV . (1993a). Br J Ophthalmol 77: 544–548.

  • Shields CL, Shields JA, De Potter P, Minelli S, Hernandez C, Brady LW et al. (1993b). Ophthalmology 100: 216–224.

  • Shields CL, Shields JA, DePotter P, Himelstein BP, Meadows AT . (1997). J Pediatr Ophthalmol Strabismus 34: 165–169.

  • Shields CL, Shields JA, Shah P . (1991). Ophthalmology 98: 395–399.

  • Simpson JL, Carson SA, Cisneros P . (2005). J Natl Cancer Inst Monogr, 87–90.

  • Singh AD, Santos CM, Shields CL, Shields JA, Eagle Jr RC . (2000). Arch Ophthalmol 118: 199–205.

  • Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM . (2001). Arch Ophthalmol 119: 41–48.

  • Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg Jr TM, Grossniklaus HE et al. (2005). Ophthalmology 112: 1151–1158.

  • Xu HJ . (2003). Ophthalmol Clin North Am 16: 621–629.

  • Xu K, Rosenwaks Z, Beaverson K, Cholst I, Veeck L, Abramson DH . (2004). Am J Ophthalmol 137: 18–23.

  • Zografos L . (2002) In: Tumeurs Intraoculaires. SFO: Paris, pp 21–64.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Balmer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Balmer, A., Zografos, L. & Munier, F. Diagnosis and current management of retinoblastoma. Oncogene 25, 5341–5349 (2006). https://doi.org/10.1038/sj.onc.1209622

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209622

Keywords

  • retinoblastoma
  • tumor suppressor gene
  • diagnosis; management

This article is cited by

Search

Quick links